Heterozygous and homozygous factor H deficiency states in a Dutch family

Clinical and Experimental Immunology

Volumn 105, Issue 3, 1996, Pages 511-516

  Fijen, C A P ^a   Kuijper, E J ^a   Te Bulte, M T ^b   Van De Heuvel, M M ^a   Holdrinet, A C J M ^c   Sim, R B ^d   Daha, M R ^b   Dankert, J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Ignatius Hospital   (Netherlands)

^d MRC Immunochemistry Unit   (United Kingdom)

Author keywords

Complement; Factor H; Meningococci; Neisseria meningitidis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

ADULT; ARTICLE; CASE REPORT; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS; MENINGITIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL;

EID: 0029848021     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-777.x     Document Type: Article

References (40)

1. Weiler JM, Daha MR, Austen KF, Fearon DT. Control of the amplification convertase by the plasma protein 31H. Proc Natl Acad Sci USA 1976; 73:3268-72.
2. Pangburn MK, Schreiber D, Müller Eberhard HJ. Human complement C3b inactivator: isolation, characterization and demonstration of an absolute requirement for the serum protein 31H for cleavage of C3b and C4b in solution. J Exp Med 1977; 146:257-70.
3. Alsenz J, Schulz TF, Lambris JD, Sim RB, Dierich MP. Structural and funclional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem J 1985; 232:841-50.
4. Pangburn MK, Atkinson MAL, Meri S. Localisation of the heparin-binding site on complement factor H. J Biol Chem 1991; 266:16847-53.
5. Pangburn MK, Müller Eberhard HJ. Complement C3 convertase: cell surface restriction of 31H control and generation of restriction on neuraminidase-treated cells. Proc Natl Acad Sci USA 1978; 75:2416-20.
6. Meri S, Pangburn MK. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of polyanion binding site on factor H. Bioch Biophys Res Commun 1994; 198:52-59.
7. Thompson RA, Winterborne MH. Hypocomplementemia due to a genetic deficiency of 31H globulin. Clin Exp Immunol 1981; 46:110-9.
8. Ross SC, Densen P. Complement deficiency states and infection: pathogenesis and consequences of Neisserial and other infections in immune deficiency. Medicine 1984; 63:243-73.
9. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:359-95.
10. Vyse TJ, Späth PJ, Davies KA, Morley BJ, Philippe P, Athenassiou P, Giles CM, Walport MJ. Hereditary complement factor I deficiency. QJ Med 1994; 87:385-401.
11. Rodriguez de Cordoba S, Lublin D, Rubinstein P, Atkinson JP. Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med 1985; 161:1189-95.
12. Ripoche J, Day AJ, Harris TJR, Sim RB. The complete amino acid sequence of human complement factor H. Biochem J 1988; 249:543-602.
13. Reid K, Bentley DR, Camphell RD, Chung LP, Sim RB, Kristensen T, Tack BF. Complement system proteins which interact with C3b or C4b. Immunol Today 1986; 7:230-4.
14. Fontaine M, Demares MJ, Koistinen V, Day AJ, Davrinche C, Sim RB, Ripoche J. Truncated forms of human complement factor H. Biochem J 1989; 258:927-30.
15. Skerka C, Timmann C, Horstmann RD, Zipfel PF. Two additional human serum proteins structurally related to complement factor H. J Immunol 1992; 148:3313-8.
16. Zipfel PF, Skerka C. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol Today 1994; 15:1216.
17. Lopez-Larrea C, Dieguez MA, Enguix A, Dominguez O, Marin B, Gomez E. A familial deficiency of complement factor H. Biochem Soc Trans 1987: 15:648-9.
18. Braï M, Misiano G, Maringhini S, Cutaja I, Hauptmann G. Combined homozygous factor H and heterozygous C2 deficiency in an Italian family. J Clin Immunol 1988; 1:50-56.
19. Nielsen HE, Christensen KC, Koch C, Thomson BS, Heegard NHH, Tranum-Jensen J. Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease. Scand J Immunol 1989; 30:711-8.
20. Levy M, Halbwachs-Mecarelli L, Gubler M-C, Kohout G, Bensenouci A, Niaudet P, Hauptmann G, Lesavre P. H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 1986; 30:949-56.
21. West CD. Nephritic factors predispose to chronic glomerulonephritis. Am J Kidney Dis 1994; 24:956-63.
22. Vogt BA, Wyatt RJ, Burke BA, Simonton SC, Kashtan CE. Inherited factor H deficiency and collagen type III glomerulopathy. Pediatr Nephrol 1995; 9:11-15.
23. Pichette V, Querin S, Schurch W, Brun G, Lehner-Netsch G, Delage JM. Familial hemolytic uremic syndrome and homozygous factor H deficiency. Am J Kidney Dis 1994; 24:936-41.
24. Wyatt RJ, Julian BA, Weinstein A, Rothfield NE, McLean RH. Partial H deficiency and glomerulonephritis in two families. J Clin Immunol 1982; 2:110-7.
25. Roodhooft AM, McLean RH, Elst E, van Acker KJ. Recurrent haemolytic uraemic syndrome and acquired hypomorphic variant of the third complement component. Pediatr Nephrol 1990; 4:597-9.
26. Fijen CAP, Kuijper EJ, Hannema AJ, Sjöholm AG, Putten JPM van. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet 1989; ii:585-8.
27. Truedsson I, Sjöholm AG, Laurell AB. Screening for complement deficiencies in the classical and alternative pathways of complement by hemolysis in gel. Acta Pathol Microbiol Scand 1981; 89:161-6.
28. Nilsson UR, Nilsson B. Simplified assays of hemolytic activity of the classical and alternative complement pathways. J Immunol Methods 1984; 72:49-59.
29. Daha MR, Bertina RM, Thompson J, Kaufmann RH, Nicholson-Weller A, Veltkamp JJ, Briët E. Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family. Clin Exp Immunol 1982; 48:733-8.
30. Daha MR, Es LA van. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages. Immunology 1981; 43:513-8.
31. 2 and IL-1. J Immunol 1990; 144:3835-40.
32. Sim RB, DiScipio RG. Purification and structural studies on the complement-system control protein 31H (Factor H). Biochem J 1982; 205:285-93.
33. Feifel E, Prodinger WM, Mölgg M, Schwaeble W, Schönitzer D, Koistinen V, Misasi R, Dierich MP. Polymorphism and deficiency of human factor H-relaled proteins p39 and p37. Immunogenetics 1992; 36:104-9.
34. Schwaeble W, Zwirner J, Schultz TF, LinkeRp, Dierich MP, Weiss EH. Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur J Immunol 1987; 17:1485.
35. Estellar C, Schwaeble W, Dierich M, Weiss EM. Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts. Eur J Immunol 1991; 21:799-802.
36. Estaller C, Koistinen V, Schwaeble W, Dierich MP, Weiss EH. Cloning of the 1.4 mRNA species of human complement factor H reveals a novel member of the short concensus repeat family related to the carboxy terminal of the classical 150 kDa molecule. J Immunol 1991;146: 3190-6.
37. Avery VM, Gordon DL. Characterization of factor H binding to human polymorphonuclear leukocytes. J Immunol 1993; 151:5545-53.
38. Misasi R, Huemer HP, Schwaeble W, Sölder E, Larcher C, Dierich MP. Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement. Eur J Immunol 1989; 19:1765-8.
39. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M. Hereditary porcine membranoproliferalive glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 1995; 95:1054-61.
40. Daha MR, van Es LA. Isolation, characterisation and mechanism of action of rat factor H. J Immunol 1982; 128:1839-43.